BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8671894)

  • 1. Effects of lipoprotein(a) on mesangial cell proliferation and viability.
    Greiber S; Krämer-Guth A; Pavenstädt H; Gutenkunst M; Schollmeyer P; Wanner C
    Nephrol Dial Transplant; 1996 May; 11(5):778-85. PubMed ID: 8671894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atherogenic lipoprotein(a) as a progression factor in glomerular diseases: studies in cultured rat mesangial cells].
    Greiber S; Gutenkunst M; Wanner C
    Immun Infekt; 1995 Apr; 23(2):50-2. PubMed ID: 7744426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of native and oxidized lipoprotein(a) with human mesangial cells and matrix.
    Krämer-Guth A; Greiber S; Pavenstädt H; Quaschning T; Winkler K; Schollmeyer P; Wanner C
    Kidney Int; 1996 May; 49(5):1250-61. PubMed ID: 8731088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) stimulates growth of human mesangial cells and induces activation of phospholipase C via pertussis toxin-sensitive G proteins.
    Mondorf UF; Piiper A; Herrero M; Olbrich HG; Bender M; Gross W; Scheuermann E; Geiger H
    Kidney Int; 1999 Apr; 55(4):1359-66. PubMed ID: 10201000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent effects of arginine vasopressin and angiotensin II on proliferation and expression of the immediate early genes c-fos, c-jun and Egr-1 in cultured rat glomerular mesangial cells.
    Schulze-Lohoff E; Köhler M; Fees H; Reindl N; Sterzel RB
    J Hypertens; 1993 Feb; 11(2):127-34. PubMed ID: 8385171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).
    Wanner C; Greiber S; Krämer-Guth A; Heinloth A; Galle J
    Kidney Int Suppl; 1997 Dec; 63():S102-6. PubMed ID: 9407434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulatory effect of lipoprotein (a) on proliferation of human mesangial cells: role of lipoprotein (a) in renal disease.
    Morishita R; Yamamoto K; Yamada S; Matsushita H; Tomita N; Sakurabayashi I; Kaneda Y; Moriguchi A; Higaki J; Ogihara T
    Biochem Biophys Res Commun; 1998 Aug; 249(2):313-20. PubMed ID: 9712693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL causes mesangial cell mitogenesis through a tyrosine kinase-dependent receptor mechanism.
    Neverov NI; Kaysen GA; Nuccitelli R; Weiss RH
    J Am Soc Nephrol; 1997 Aug; 8(8):1247-56. PubMed ID: 9259351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression.
    Grandaliano G; Ranieri E; Monno R; Gesualdo L; Schena F
    Exp Nephrol; 1999; 7(3):229-35. PubMed ID: 10352363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
    Okada M; Takemura T; Yanagida H; Yoshioka K
    Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered nitric oxide production and exogenous nitric oxide do not affect the proliferation of rat mesangial cells.
    Mohaupt M; Schoecklmann HO; Schulze-Lohoff E; Sterzel RB
    J Hypertens; 1994 Apr; 12(4):401-8. PubMed ID: 8064164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bradykinin stimulates c-fos expression, AP-1-DNA binding activity and proliferation of rat glomerular mesangial cells.
    el-Dahr SS; Dipp S; Yosipiv IV; Baricos WH
    Kidney Int; 1996 Dec; 50(6):1850-5. PubMed ID: 8943466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-AP-1 activity of all-trans retinoic acid in glomerular mesangial cells.
    Simonson MS
    Am J Physiol; 1994 Nov; 267(5 Pt 2):F805-15. PubMed ID: 7977784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of Lp(a) on human mesangial cell proliferation, adhesion and migration].
    Xu K; Song HM; Wei M
    Zhonghua Er Ke Za Zhi; 2004 Oct; 42(10):734-6. PubMed ID: 16221338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of low density lipoprotein with rat mesangial cells.
    Wasserman J; Santiago A; Rifici V; Holthofer H; Scharschmidt L; Epstein M; Schlondorff D
    Kidney Int; 1989 May; 35(5):1168-74. PubMed ID: 2770101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II induces hypertrophy and hyperplasia in adult human mesangial cells.
    Orth SR; Weinreich T; Bönisch S; Weih M; Ritz E
    Exp Nephrol; 1995; 3(1):23-33. PubMed ID: 7712140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
    Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
    Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of three mitogen-activated protein kinases on lipoprotein (a)-induced human mesangial cell proliferation.
    Song HM; Wei M; Xu K; Li XW
    Chin Med J (Engl); 2010 Jan; 123(2):216-20. PubMed ID: 20137374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lovastatin inhibits proliferation of rat mesangial cells.
    O'Donnell MP; Kasiske BL; Kim Y; Atluru D; Keane WF
    J Clin Invest; 1993 Jan; 91(1):83-7. PubMed ID: 8423236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pravastatin on type IV collagen secretion and mesangial cell proliferation.
    Nishimura M; Tanaka T; Yasuda T; Kurakata S; Kitagawa M; Yamada K; Saito Y; Hirai A
    Kidney Int Suppl; 1999 Jul; 71():S97-100. PubMed ID: 10412748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.